비증식당뇨망막증과 증식당뇨망막증에서 범망막광응고술 후형광안저조영술로 측정한 망막순환시간의 변화
Changes in Retinal Circulation Time after Panretinal Photocoagulation in Patients with Nonproliferative and Proliferative Diabetic Retinopathy
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
목적: 심한 비증식당뇨망막병증과 초기 증식당뇨망막병증 환자에게 범망막광응고술 시행 후 망막순환시간의 변화량을 통해 범망막광응고술의 망막혈류 순환 개선 효과가 당뇨망막병증 중증도별로 차이가 있는지 비교하고자 한다. 대상과 방법: 심한 비증식당뇨망막병증과 초기 증식당뇨망막병증 환자 중 범망막광응고술이 필요하다고 판단되는 환자들을 대상으로 범망막광응고술 시행 전후로 비디오 형광안저혈관조영술을 시행하여 동맥순환시간, 동정맥통과시간, 정맥충만시간의 변화를 당뇨망막병증의 중증도에 따른 환자군으로 나누어 비교 분석하였다. 결과: 총 33명 환자에 심한 비증식당뇨망막병증 환자 17명과 초기 증식당뇨망막병증 환자 16명이 포함되었다. 동맥순환시간과 동정맥통과시간은 심한 비증식당뇨망막병증 환자군(p=0.927, p=0.138)과 초기 증식당뇨망막병증 환자군(p=0.137, p=0.268)에서 범망막광응고술 전후로 유의한 차이가 없었다. 정맥충만시간은 심한 비증식당뇨망막병증 환자군(p=0.000)과 초기 증식당뇨망막병증 환자군(p=0.022) 모두 범망막광응고술 시행 후 유의하게 단축되었다. 하지만 정맥충만시간의 단축 정도는 심한 비증식당뇨망막병증 환자군과 초기 증식당뇨망병증 환자군 사이에 유의한 차이가 없었다(p=0.217). 결론: 정맥충만시간의 감소를 통해 심한 비증식당뇨망막병증 환자와 초기 증식당뇨망막병증 환자에게 범망막광응고술 시행 후 망막혈류 순환 개선 효과를 확인할 수 있었다. 따라서, 심한 비증식당뇨망막병증 환자와 초기 증식당뇨망막병증 환자에서 범망막광응고술시행을 통해 얻을 수 있는 혈류 개선 효과가 비슷하다고 유추해볼 수 있다.
Abstract
Purpose: To explore whether panretinal photocoagulation (PRP) improved retinal blood circulation in patients with diabetic retinopathyof various levels of severity based on changes in the retinal circulation time as measured by video fluorescein fundusangiography. Methods: We recruited patients with severe diabetic retinopathy indicated for PRP; we performed video fluorescein fundus angiographybefore and after PRP. We measured changes in the arterial circulation time (ACT), arteriovenous passage time (APT),and venous filling time (VFT) in patients with diabetic retinopathy of varying severity, and compared the findings. We recordedHbA1c levels and hypertension status. Results: We enrolled 33 patients, 17 with severe nonproliferative diabetic retinopathy (NPDR) and 16 with early proliferative diabeticretinopathy (PDR). After PRP, neither the ACT nor the APT changed significantly in patients with severe NPDR (p = 0.927,p = 0.138) or early PDR (p = 0.137, p = 0.268). After PRP, the VFT was significantly reduced in patients with both severe NPDR(p = 0.000) and early PDR (p = 0.022). The VFT reductions were similar in both groups (p = 0.217). Conclusions: In patients with severe NPDR and early PDR, improvements in retinal blood circulation after PRP are reflected byreductions in the VFT evident on video fluorescein fundus angiography. We speculate that the improvements are similar in patientswith severe NPDR and early PDR.
참고문헌 (22)
- Resnikoff S, "Global data on visual impairment in the year 2002", Bull World Health Organ, 82, pp.844~851 (2004)
- Schachat AP, "Ryan's retina", pp.1038~1048 (2017), Elsevier
- Feke GT, "Retinal circulatory changes related to retinopathy progression in insulin-dependent diabetes mellitus", Ophthalmology, 92, pp.1517~1522 (1985)
- Grunwald JE, "Effect of panretinal photocoagulation on retinal blood flow in proliferative diabetic retinopathy", Ophthalmology, 93, pp.590~595 (1986)
- Grunwald JE, "Retinal blood flow regulation and the clinical response to panretinal photocoagulation in proliferative diabetic retinopathy", Ophthalmology, 96, pp.1518~1522 (1989)
- Fujio N, "Regional retinal blood flow reduction following half fundus photocoagulation treatment", Br J Ophthalmol, 78, pp.335~338 (1994)
- Iwase T, "Effects of photocoagulation on ocular blood flow in patients with severe non-proliferative diabetic retinopathy", PLoS One, 12, pp.e0174427~ (2017)
- Feke GT, "Laser Doppler measurements of the effect of panretinal photocoagulation on retinal blood flow", Ophthalmology, 89, pp.757~762 (1982)
- Grunwald JE, "Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus", Ophthalmology, 91, pp.1447~1452 (1984)
- Yang YS, "A study on microcirculation time including retinal periphery in diabetic retinopathy using the fluorescein angiography", J Korean Ophthalmol Soc, 41, pp.931~937 (2000)
- Early Treatment Diabetic Retinopathy Study Research Group, "Early photocoagulation for diabetic retinopathy. ETDRS report number 9", Ophthalmology, 98(5 Suppl), pp.766~785 (1991)
- 장성수, "증식당뇨망막병증에서 망막정맥충만시간의 임상적 유용성", 대한안과학회지, 45(6), pp.15~15 (2004), 대한안과학회
- Niki T, "Distribution of capillary nonperfusion in early-stage diabetic retinopathy", Ophthalmology, 91, pp.1431~1439 (1984)
- Bressler NM, "Panretinal photocoagulation for proliferative diabetic retinopathy", N Engl J Med, 365, pp.1520~1526 (2011)
- 박창현, "기관내 삽관시 혈역학적 변동을 최소화하기 위한 Alfentanil 적정 용량은?", Korean Journal of Anesthesiology, 44(3), pp.338~345 (2003), 대한마취통증의학회
- Kim YW, "The clinical significance of venous filling time through panretinal photocoagulation in proliferative diabetic retinopathy", Korean J Ophthalmol, 19, pp.179~182 (2005)
- UK Prospective Diabetes Study (UKPDS) Group, "Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)", Lancet, 352, pp.837~853 (1998)
- Davis MD, "Risk factors for highrisk proliferative diabetic retinopathy and severe visual loss : Early Treatment Diabetic Retinopathy Study Report #18", Invest Ophthalmol Vis Sci, 39, pp.233~252 (1998)
- Klein R, "The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes", Ophthalmology, 105, pp.1801~1815 (1998)
- Wautier JL, "Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats", J Clin Invest, 97, pp.238~243 (1996)
- American Diabetes Association, "Standards of medical care for patients with diabetes mellitus", Diabetes Care, 26(Suppl 1), pp.S33~S50 (2003)
- Kotoula MG, "Metabolic control of diabetes is associated with an improved response of diabetic retinopathy to panretinal photocoagulation", Diabetes Care, 28, pp.2454~2457 (2005)
